ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 47

$612K Total Retail Price of All Prescriptions

Rank: 13 out of 47

192 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 192 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

15% of this provider’s 192 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 30.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
WARFARIN SODIUM 366 272 1 9
FUROSEMIDE 347 312 2 1
LISINOPRIL 302 262 3 2
LEVOTHYROXINE SODIUM 283 263 4 3
QUETIAPINE FUMARATE 258 223 5 27
DONEPEZIL HCL 170 165 6 12
CITALOPRAM HBR 169 138 7 10
SIMVASTATIN 166 154 8 5
AMLODIPINE BESYLATE 164 130 9 7
METOPROLOL TARTRATE 161 159 10 6
NAMENDA 156 144 11 17
SERTRALINE HCL 145 142 12 15
OMEPRAZOLE 145 110 12 4
MIRTAZAPINE 143 99 14 18
LANTUS SOLOSTAR 139 108 15 64
HYDROCODONE-ACETAMINOPHEN 115 98 S3 16 8
POTASSIUM CHLORIDE 115 101 16 14
ATORVASTATIN CALCIUM 105 93 18 20
GABAPENTIN 105 80 18 11
CYMBALTA 98 72 20 35
RISPERIDONE 95 85 21 28
SEROQUEL 93 81 22 86
POLYETHYLENE GLYCOL 3350 92 80 23 41
METFORMIN HCL 89 70 24 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 73 25 52
LANTUS 82 69 26 25
CIPROFLOXACIN HCL 82 62 26 58
CARVEDILOL 78 76 28 21
METOPROLOL SUCCINATE 76 75 29 24
CLOPIDOGREL 70 61 30 32
DIVALPROEX SODIUM 69 46 31 26
FLUOXETINE HCL 68 66 32 97
ALENDRONATE SODIUM 65 65 33 45
PANTOPRAZOLE SODIUM 64 51 34 51
RANITIDINE HCL 63 51 35 40
LEVOFLOXACIN 63 41 35 75
KLOR-CON M20 61 48 37 38
DIGOXIN 60 40 38 48
ATENOLOL 57 47 39 30
IMIPENEM-CILASTATIN SODIUM 57 26 10 39 287
KLOR-CON M10 55 42 41 83
LACTULOSE 55 55 41 100
OXYCODONE-ACETAMINOPHEN 54 44 S2 43 23
NOVOLIN R 54 45 43 98
CEPHALEXIN 54 41 43 93
GENTAMICIN SULFATE 54 29 43 296
PLAVIX 54 50 43 56
NOVOLOG 53 44 48 56
HALOPERIDOL 52 32 49 88
CARBIDOPA-LEVODOPA 51 51 50 49
EXELON 51 51 50 44
TRAMADOL HCL 51 0 50 13
TRAVATAN Z 51 42 50 134
OXYCODONE HCL 50 42 S2 54 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.